These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38425844)

  • 1. Oncolytic alphavirus replicons mediated recruitment and activation of T cells.
    Bhatt DK; Meuleman SL; Hoogeboom BN; Daemen T
    iScience; 2024 Mar; 27(3):109253. PubMed ID: 38425844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.
    Colmenero P; Chen M; Castaños-Velez E; Liljeström P; Jondal M
    Int J Cancer; 2002 Apr; 98(4):554-60. PubMed ID: 11920615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.
    van de Wall S; Walczak M; van Rooij N; Hoogeboom BN; Meijerhof T; Nijman HW; Daemen T
    Vaccines (Basel); 2015 Mar; 3(2):221-38. PubMed ID: 26343186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.
    Hidmark AS; Nordström EK; Dosenovic P; Forsell MN; Liljeström P; Karlsson Hedestam GB
    J Virol; 2006 Jul; 80(14):7100-10. PubMed ID: 16809315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
    Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
    J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.
    Fleeton MN; Sheahan BJ; Gould EA; Atkins GJ; Liljestr M P
    J Gen Virol; 1999 May; 80 ( Pt 5)():1189-1198. PubMed ID: 10355766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prime-boost immunizations with a virosomal and an alphavirus replicon vaccine.
    Walczak M; de Mare A; Riezebos-Brilman A; Regts J; Hoogeboom BN; Visser JT; Fiedler M; Jansen-Dürr P; van der Zee AG; Nijman HW; Wilschut J; Daemen T
    Mol Pharm; 2011 Feb; 8(1):65-77. PubMed ID: 20825215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of P815 tumor immunity by DNA-based recombinant Semliki Forest virus or replicon DNA expressing the P1A gene.
    Ni B; Lin Z; Zhou L; Wang L; Jia Z; Zhou W; Diciommo DP; Zhao J; Bremner R; Wu Y
    Cancer Detect Prev; 2004; 28(6):418-25. PubMed ID: 15582265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).
    Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ
    Vaccine; 2009 Dec; 27(52):7451-8. PubMed ID: 19450640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.
    Knudsen ML; Ljungberg K; Kakoulidou M; Kostic L; Hallengärd D; García-Arriaza J; Merits A; Esteban M; Liljeström P
    J Virol; 2014 Nov; 88(21):12438-51. PubMed ID: 25122792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.
    Burke S; Shergold A; Elder MJ; Whitworth J; Cheng X; Jin H; Wilkinson RW; Harper J; Carroll DK
    Cancer Immunol Immunother; 2020 Jun; 69(6):1015-1027. PubMed ID: 32088771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform.
    Marchese AM; Chiale C; Moshkani S; Robek MD
    J Interferon Cytokine Res; 2020 Feb; 40(2):92-105. PubMed ID: 31633442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.
    Ip PP; Boerma A; Regts J; Meijerhof T; Wilschut J; Nijman HW; Daemen T
    Mol Ther; 2014 Apr; 22(4):881-90. PubMed ID: 24370701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.
    Draghiciu O; Nijman HW; Hoogeboom BN; Meijerhof T; Daemen T
    Oncoimmunology; 2015 Mar; 4(3):e989764. PubMed ID: 25949902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
    Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
    BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
    Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
    Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.